A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. - Wikidata - awgldk - TriplyDB

A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.

A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.

http://www.wikidata.org/entity/Q33815728

about

Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis New Insights about Treg and Th17 Cells in HIV Infection and Disease Progression Homeostasis and function of regulatory T cells in HIV/SIV infection Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088)Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers Interferon-alpha administration enhances CD8+ T cell activation in HIV infection HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients.Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy Longitudinal changes of peripheral blood DC subsets and regulatory T cells in Chinese chronic HIV-1-infected patients during antiretroviral therapy.Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients.Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis Persistent immune activation in chronic HIV infection: do any interventions work?Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection.Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil.Immune correlates of herpes zoster in HIV-infected children and youth.Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells.Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summary.Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes.The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon Infection Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study.Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature.Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³.CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection.Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study.Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers.Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals.Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.

P2860

Q26744626-048731A8-BE04-4F41-86FB-FB2B33EA1B0A Q26747110-077BD589-1E9B-47A6-9C6F-2758518D905B Q26777036-8CAEF079-FE7D-40EA-9EA4-8489C0DCD268 Q26995345-532DD858-E3B1-4F40-ABB8-2DC5A4F8CCC6 Q27003380-2A81244B-9BB7-40C4-A22F-8865895820D3 Q30362489-891FFDDD-3D3E-4801-B437-44AE77ABC9F3 Q30426654-6479CC88-AB78-4C7D-90F2-B30D98766D6B Q33575261-2F7D327C-844A-457A-8407-E1383C8C83D2 Q33828349-16FE6F6A-8A89-45B7-8190-B46461097A6C Q33828507-8B1A2852-7747-4790-9611-A6433D3E04EB Q34145979-CC45D7A0-0F83-498C-8493-46F972CBA407 Q34159418-38685B75-92F6-4CCD-92E3-67886230FDC8 Q34206123-37354456-F5D6-4091-9AED-C9A89492CCAE Q34305055-19F821C8-2690-4DE9-A96C-6FE5F5F53C21 Q34534197-373F7AE3-5393-42D3-B329-30A17D7EB074 Q34711777-144A57F2-1C3C-4C2D-AA37-67CD9FAEF298 Q34841938-AD5BA3E8-A36B-48D7-B044-E1BEAC2B39F9 Q34851102-B98E11A5-7F26-43DB-8BC2-A1E1AB80ECF9 Q34943158-2D55C9C2-AD68-4CCE-A4FD-099E92D48E76 Q35018065-8E9F3357-6720-462A-A006-A892524D889D Q35363011-68254D00-501C-4620-B7CB-F1E8CDD5DFFC Q35531527-426C1A2E-D01E-43C0-A169-3AC152DDFFEE Q35680467-DDD63188-EA0E-4483-944E-C7053A7AEA66 Q35826138-7DA8FD22-75D1-4E52-8A26-9AF65C1EC5CC Q35897923-237CCF53-CB65-4D2C-96B6-E78A55AD5D87 Q35904496-C618BE0E-435B-46DC-9E32-95589FBE044C Q36010933-7A8EFB56-0368-4273-B6BE-4A48CEB423EC Q36112824-D22FE67B-6735-4F4C-961F-68B88E64754F Q36625426-1AFFAC08-DB32-4E8E-8706-557F004BEEDA Q36665336-21C46E42-BD13-4B1D-80BF-633741DCC805 Q36833017-510EF654-D447-4B57-8BA9-F6382514F333 Q37025746-5DDD3CCA-584A-4409-AC43-8289D12BF285 Q37054806-B9036474-AEC5-4AAC-A9B0-F397785D739E Q37076185-BDFF8E39-6871-44D7-BB2C-3AEF93AA03C3 Q37098390-7E23BCB8-B91E-4721-8D31-0609C3CAA4C1 Q37458908-46BB90EB-6C8F-49A1-8570-F48F0CCF91BC Q37490654-D51AC5D2-1722-455C-A318-373F89F1B7E0 Q37584487-02AE92A6-BBBF-41AA-A2ED-189704A3BC44 Q37620568-AC9B7869-B0FF-4CB2-A086-4C6FC5598B2E Q37695072-DCED857D-32D2-444F-81B0-4B960B42D0CA

P2860

A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.

http://www.wikidata.org/entity/Q33815728

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A low T regulatory cell respon ...... activation in HIV controllers.

@ast

A low T regulatory cell respon ...... activation in HIV controllers.

@en

type

label

A low T regulatory cell respon ...... activation in HIV controllers.

@ast

A low T regulatory cell respon ...... activation in HIV controllers.

@en

prefLabel

A low T regulatory cell respon ...... activation in HIV controllers.

@ast

A low T regulatory cell respon ...... activation in HIV controllers.

@en

P1433

Q33815728-A839D730-F223-4E10-8B6C-2E4FD6A17549

P1476

Q33815728-5EE651C3-305D-418D-B786-BC182CC79E2D

P2093

Q33815728-0B1CBF67-5EA0-4511-A3BE-5B7B9A9C3D96

Q33815728-11D3A851-FAEF-4FE3-9183-30D0E77CAF3A

Q33815728-38315D91-3E62-4A05-A90E-CD5ADD2124BD

Q33815728-43F2FD68-350D-4FE7-9E50-89839F792FAD

Q33815728-44AAE732-D427-487D-9AE9-A544883AA345

Q33815728-7505B8D0-E7E6-4E25-A3D0-9A1D44951291

Q33815728-7C09349A-E14E-43D2-89BA-D41B84AA5CEC

Q33815728-C85A1B2C-6BE2-40B6-B867-BFDFA5A17260

Q33815728-F967EBFB-ECB1-4046-9F4E-00DBC4AD0DA7

Q33815728-FF52CAB8-4947-4002-AC65-CF6D7247AFC6

P2860

Q33815728-035A13E4-99A0-40B9-B64F-F772AB8AEA4D

Q33815728-0381E9A9-4DB3-4A5A-AD34-9A278D09E166

Q33815728-04028418-1602-4C50-B5FF-E92DDF79AEED

Q33815728-05C09943-1009-4480-9DFB-A1A23F3F60EA

Q33815728-0A00AB51-6288-4CB5-A68F-77C32E057012

Q33815728-0DC8E216-F303-448E-A03C-5301585D4A82

Q33815728-0E95BA0B-D457-412B-B5E1-16B9954152C3

Q33815728-1792E4C2-7721-4388-88A5-65D0A78C8569

Q33815728-1949DE03-3CEE-48FF-BFB5-DFA305BFFA10

Q33815728-1DC077DB-8691-4A2A-929C-4D52A48CB3E3

P304

Q33815728-36DAC8FE-2E1C-4B8F-BE93-4829CA9739AA

P31

Q33815728-60B41A61-4761-46AA-949F-043170529247

P356

Q33815728-030444DA-B01D-47BF-A3DD-72C1560E9C3C

P407

Q33815728-5C175C71-5102-4691-978E-2DA56BD81886

P433

Q33815728-56CA5340-9F11-4BA0-B3A8-B2E89ED6CABB

P478

Q33815728-F1308D89-A592-48B6-91B9-CF7579BA3615

P50

Q33815728-2E5E7DF6-6216-47E2-B8D7-90169ADAD312

Q33815728-FD26BDB7-9836-4C6E-B98C-99D830C74813

P577

Q33815728-757199AE-B62B-4953-B464-936F392253E5

P5875

Q33815728-0FA95728-18E6-4DD5-AA7E-99EDE0E355E9

P698

Q33815728-F1A35AEB-64E6-4DE3-9053-0D1CA393F274

P932

Q33815728-0319F40D-C7DC-46BE-81FE-FEA5852A3634

P356

JOURNAL.PONE.0015924

P1433

P1476

A low T regulatory cell respon ...... activation in HIV controllers.

@en

P2093

Alan L Landay

http://www.w3.org/2001/XMLSchema#string

Brinda Emu

http://www.w3.org/2001/XMLSchema#string

Cicely Brooks

http://www.w3.org/2001/XMLSchema#string

Elizabeth Sinclair

http://www.w3.org/2001/XMLSchema#string

Hiroyu Hatano

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Martinson

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Martin

http://www.w3.org/2001/XMLSchema#string

Joseph M McCune

http://www.w3.org/2001/XMLSchema#string

Peter W Hunt

http://www.w3.org/2001/XMLSchema#string

Philip J Norris

http://www.w3.org/2001/XMLSchema#string

P2860

Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1

HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells

Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans

Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

A whole-genome association study of major determinants for host control of HIV-1

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

In vitro whole-genome analysis identifies a susceptibility locus for HIV-1.

P304

e15924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0015924

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Michael P. Busch

P577

2011-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49821032

http://www.w3.org/2001/XMLSchema#string

P698

21305005

http://www.w3.org/2001/XMLSchema#string

P932

3031543

http://www.w3.org/2001/XMLSchema#string